ID

20114

Description

Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00290004

Link

https://clinicaltrials.gov/show/NCT00290004

Keywords

Versions (1)
  1. 2/7/17 2/7/17 -
Uploaded on

February 7, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

No comments

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Chronic Lymphocytic Leukemia NCT00290004

English

Eligibility Chronic Lymphocytic Leukemia NCT00290004

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
≥ 18 years old
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
cll as defined by the nci 96 criteria (exception; patients may have bright surface immunoglobulin staining if negative for t[11;14] translocation or cyclin d1) or sll as defined by who classification criteria and is refractory or relapsed as defined by one of the following:
Description

Chronic Lymphocytic Leukemia | Surface immunoglobulins Staining Clear | t(11;14)(q13;q32) Negative | Cyclin D1 Negative | B-cell small lymphocytic lymphoma refractory | B-cell small lymphocytic lymphoma recurrent

Data type

boolean

Alias
UMLS CUI [1]
C0023434
UMLS CUI [2,1]
C0034789
UMLS CUI [2,2]
C1704680
UMLS CUI [2,3]
C2963144
UMLS CUI [3,1]
C1515705
UMLS CUI [3,2]
C1513916
UMLS CUI [4,1]
C0174680
UMLS CUI [4,2]
C1513916
UMLS CUI [5]
C0855097
UMLS CUI [6]
C0855096
refractory disease: progressive disease while on therapy
Description

Refractory Disease | Progressive Disease while Therapeutic procedure

Data type

boolean

Alias
UMLS CUI [1]
C1514815
UMLS CUI [2,1]
C1335499
UMLS CUI [2,2]
C0750519
UMLS CUI [2,3]
C0087111
relapsed disease: progressive disease after at least one treatment course of therapy with disease response or stabilization
Description

Recurrent disease | Therapeutic procedure Course Quantity Disease Response | Therapeutic procedure Course Quantity Disease Stabilization | Progressive Disease

Data type

boolean

Alias
UMLS CUI [1]
C0277556
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0750729
UMLS CUI [2,3]
C1265611
UMLS CUI [2,4]
C1704632
UMLS CUI [3,1]
C0087111
UMLS CUI [3,2]
C0750729
UMLS CUI [3,3]
C1265611
UMLS CUI [3,4]
C0012634
UMLS CUI [3,5]
C1293130
UMLS CUI [4]
C1335499
ecog performance status score of 0, 1, or 2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
willing and able to provide written informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
laboratory values of:
Description

Laboratory Results

Data type

boolean

Alias
UMLS CUI [1]
C1254595
platelet count < 30,000/µl
Description

Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0032181
ast or alt > 2 x uln (upper limit of normal)
Description

Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
total bilirubin > 2 x uln
Description

Serum total bilirubin measurement

Data type

boolean

Alias
UMLS CUI [1]
C1278039
creatinine > 2 mg/dl
Description

Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C0201976
chemotherapy, radiation therapy, immunotherapy, systemic corticosteroids (> 10 mg oral prednisone or equivalent), or systemic biologic anticancer therapy within 21 days before beginning study treatment
Description

Chemotherapy Malignant Neoplasms | Therapeutic radiology procedure Malignant Neoplasms | Immunotherapy Malignant Neoplasms | CORTICOSTEROIDS FOR SYSTEMIC USE Malignant Neoplasms | Prednisone Oral Dose | Prednisone Oral Equivalent Dose | Biological treatment Systemic Malignant Neoplasms

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0006826
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0006826
UMLS CUI [3,1]
C0021083
UMLS CUI [3,2]
C0006826
UMLS CUI [4,1]
C3653708
UMLS CUI [4,2]
C0006826
UMLS CUI [5,1]
C3216040
UMLS CUI [5,2]
C0178602
UMLS CUI [6,1]
C3216040
UMLS CUI [6,2]
C0205163
UMLS CUI [6,3]
C0178602
UMLS CUI [7,1]
C1531518
UMLS CUI [7,2]
C0205373
UMLS CUI [7,3]
C0006826
major surgery or hospitalization for a serious illness within the last 3 months
Description

Major surgery Illness Serious | Hospitalization Illness Serious

Data type

boolean

Alias
UMLS CUI [1,1]
C0679637
UMLS CUI [1,2]
C0221423
UMLS CUI [1,3]
C0205404
UMLS CUI [2,1]
C0019993
UMLS CUI [2,2]
C0221423
UMLS CUI [2,3]
C0205404
greater than three prior regimens (where a regimen is defined as a treatment for cll/sll given initially or after disease progression)
Description

Regimen Quantity | Therapeutic procedure Initial Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Therapeutic procedure Post Disease Progression

Data type

boolean

Alias
UMLS CUI [1,1]
C0040808
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0205265
UMLS CUI [2,3]
C1302547
UMLS CUI [3,1]
C1302547
UMLS CUI [3,2]
C0087111
UMLS CUI [3,3]
C0687676
UMLS CUI [3,4]
C0242656
prior malignancy requiring current or prior treatment within the past 5 years, except for cervical neoplasia in situ and non-melanomatous skin cancer
Description

Malignant Neoplasms Requirement Therapeutic procedure | Carcinoma in situ of uterine cervix | Skin carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0087111
UMLS CUI [2]
C0851140
UMLS CUI [3]
C0699893
uncontrolled hypertension
Description

Uncontrolled hypertension

Data type

boolean

Alias
UMLS CUI [1]
C1868885
Back to the top of the page

Similar models

Eligibility Chronic Lymphocytic Leukemia NCT00290004

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
≥ 18 years old
boolean
C0001779 (UMLS CUI [1])
Chronic Lymphocytic Leukemia | Surface immunoglobulins Staining Clear | t(11;14)(q13;q32) Negative | Cyclin D1 Negative | B-cell small lymphocytic lymphoma refractory | B-cell small lymphocytic lymphoma recurrent
Item
cll as defined by the nci 96 criteria (exception; patients may have bright surface immunoglobulin staining if negative for t[11;14] translocation or cyclin d1) or sll as defined by who classification criteria and is refractory or relapsed as defined by one of the following:
boolean
C0023434 (UMLS CUI [1])
C0034789 (UMLS CUI [2,1])
C1704680 (UMLS CUI [2,2])
C2963144 (UMLS CUI [2,3])
C1515705 (UMLS CUI [3,1])
C1513916 (UMLS CUI [3,2])
C0174680 (UMLS CUI [4,1])
C1513916 (UMLS CUI [4,2])
C0855097 (UMLS CUI [5])
C0855096 (UMLS CUI [6])
Refractory Disease | Progressive Disease while Therapeutic procedure
Item
refractory disease: progressive disease while on therapy
boolean
C1514815 (UMLS CUI [1])
C1335499 (UMLS CUI [2,1])
C0750519 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
Recurrent disease | Therapeutic procedure Course Quantity Disease Response | Therapeutic procedure Course Quantity Disease Stabilization | Progressive Disease
Item
relapsed disease: progressive disease after at least one treatment course of therapy with disease response or stabilization
boolean
C0277556 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0750729 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C1704632 (UMLS CUI [2,4])
C0087111 (UMLS CUI [3,1])
C0750729 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0012634 (UMLS CUI [3,4])
C1293130 (UMLS CUI [3,5])
C1335499 (UMLS CUI [4])
ECOG performance status
Item
ecog performance status score of 0, 1, or 2
boolean
C1520224 (UMLS CUI [1])
Informed Consent
Item
willing and able to provide written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Laboratory Results
Item
laboratory values of:
boolean
C1254595 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count < 30,000/µl
boolean
C0032181 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
ast or alt > 2 x uln (upper limit of normal)
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Serum total bilirubin measurement
Item
total bilirubin > 2 x uln
boolean
C1278039 (UMLS CUI [1])
Creatinine measurement, serum
Item
creatinine > 2 mg/dl
boolean
C0201976 (UMLS CUI [1])
Chemotherapy Malignant Neoplasms | Therapeutic radiology procedure Malignant Neoplasms | Immunotherapy Malignant Neoplasms | CORTICOSTEROIDS FOR SYSTEMIC USE Malignant Neoplasms | Prednisone Oral Dose | Prednisone Oral Equivalent Dose | Biological treatment Systemic Malignant Neoplasms
Item
chemotherapy, radiation therapy, immunotherapy, systemic corticosteroids (> 10 mg oral prednisone or equivalent), or systemic biologic anticancer therapy within 21 days before beginning study treatment
boolean
C0392920 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
C0021083 (UMLS CUI [3,1])
C0006826 (UMLS CUI [3,2])
C3653708 (UMLS CUI [4,1])
C0006826 (UMLS CUI [4,2])
C3216040 (UMLS CUI [5,1])
C0178602 (UMLS CUI [5,2])
C3216040 (UMLS CUI [6,1])
C0205163 (UMLS CUI [6,2])
C0178602 (UMLS CUI [6,3])
C1531518 (UMLS CUI [7,1])
C0205373 (UMLS CUI [7,2])
C0006826 (UMLS CUI [7,3])
Major surgery Illness Serious | Hospitalization Illness Serious
Item
major surgery or hospitalization for a serious illness within the last 3 months
boolean
C0679637 (UMLS CUI [1,1])
C0221423 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0019993 (UMLS CUI [2,1])
C0221423 (UMLS CUI [2,2])
C0205404 (UMLS CUI [2,3])
Regimen Quantity | Therapeutic procedure Initial Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Therapeutic procedure Post Disease Progression
Item
greater than three prior regimens (where a regimen is defined as a treatment for cll/sll given initially or after disease progression)
boolean
C0040808 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0205265 (UMLS CUI [2,2])
C1302547 (UMLS CUI [2,3])
C1302547 (UMLS CUI [3,1])
C0087111 (UMLS CUI [3,2])
C0687676 (UMLS CUI [3,3])
C0242656 (UMLS CUI [3,4])
Malignant Neoplasms Requirement Therapeutic procedure | Carcinoma in situ of uterine cervix | Skin carcinoma
Item
prior malignancy requiring current or prior treatment within the past 5 years, except for cervical neoplasia in situ and non-melanomatous skin cancer
boolean
C0006826 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0851140 (UMLS CUI [2])
C0699893 (UMLS CUI [3])
Uncontrolled hypertension
Item
uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial